Please login to the form below

Not currently logged in
Email:
Password:

Innate Pharma

This page shows the latest Innate Pharma news and features for those working in and with pharma, biotech and healthcare.

AZ swells immuno-oncology pipeline with Innate deal

AZ swells immuno-oncology pipeline with Innate deal

Deal gives access to natural killer cell immunotherapy. AstraZeneca has enlisted the aid of France’s Innate Pharma as it tries to make up ground in immuno-oncology, licensing a ... For another $20m, AZ also gets an option on four other immuno-oncology

Latest news

  • Inside the patient-centricity bubble Inside the patient-centricity bubble

    The hybrid model. However, ringing true to pharma, innovation comes at a price. ... Making an innate plea to pharma, he urged the industry to “stop thinking binary”.

  • Bad news for Innate Pharma as BMS-backed drug stumbles Bad news for Innate Pharma as BMS-backed drug stumbles

    Lirilumab combination fails to show additional benefit in SCCHN patients. French biotech Innate Pharma says it can’t see a development path forward for its lead cancer drug lirilumab after another ... and Innate indicated at the time that it was

  • Sanofi and Novartis snap up immuno-oncology candidates Sanofi and Novartis snap up immuno-oncology candidates

    Now, the French pharma firm has added a 400m collaboration with Innate Pharma to develop bi-specific (double-headed) antibodies that will target both tumour antigens and NKp46, an activating receptor

  • HCV hope on the horizon

    US. Others in phase II trials are the T-lymphocyte stimulants GI 5005 (Tarmogen; GlobeImmune), a recombinant yeast product, and IPH 1101 (Phosphostim; Innate Pharma), a small molecule compound that is ... Romark Laboratories has a small molecule signal

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    hepatitis B virus (HBV). Strategic. collaboration ‐. development. $445m. Innate Pharma/. ... Acquisition. $244m. Zealand/. Royalty Pharma. Royalty streams and milestones for Soliqua 100/33/.

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    and Innate Pharma (IPH53) – both of which work by blocking immunosuppressive mechanisms in the tumour microenvironment. ... up innate immune responses, and Cancer Research UK is repurposing an AZ chemokine CCR4 receptor drug (AZD2098) originally

  • Deal Watch January 2016 Deal Watch January 2016

    The second deal closed by Sanofi was with Innate Pharma to create new bispecific antibodies, which aim to kill tumour cells through the activation of NKp46. ... 502.3. Innate Pharma/ Sanofi. Collaboration . Collaboration to develop 2 bispecific NK cell

  • Medius Deal Watch table for April 2015 Medius Deal Watch table for April 2015

    Gene therapy platform - CV diseases. 2, 300. Innate Pharma / AstraZeneca. ... 225. Intec Pharma/ Undisclosed Company. R&D collaboration plus option. Accordian Pill (gastro retentive delivery system).

  • Pharma deals in April 2015 Pharma deals in April 2015

    Continuing to build the oncology portfolio and looking to score a win with a combination therapy, AZ in-licensed Innate Pharma's IPH2201 for both monotherapy and also in combination with ... Roche has also been forging an immunotherapy alliance this month

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics